Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Monitoring in Intensive Care Unit of Neuromuscular Blocking Agents (NMBA) Used for Acute Respiratory Distress Syndrome (ARDS) After Cardiothoracic Surgery

NCT02546947 is registered in ClinicalTrials.gov with Centre Chirurgical Marie Lannelongue as lead sponsor.

NCT NCT02546947
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02546947 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Monitoring in Intensive Care Unit of Neuromuscular Blocking Agents (NMBA) Used for Acute Respiratory Distress Syndrome (ARDS) After Cardiothoracic Surgery
Lead sponsor
Centre Chirurgical Marie Lannelongue
Phase
Not applicable
Overall status
Completed
Start date
June 30, 2015
Completion date
December 31, 2016
Enrollment
82 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

acute respiratory distress syndrome